Authors
Loading...
This study demonstrates p22phox's role in stabilizing SERCA2a and reducing cardiac dysfunction, indicating significant therapeutic potential.
Nakada et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: